New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Predicting postpartum hospitalizations among high-risk populations

Predicting postpartum hospitalizations among high-risk populations

byColumbia University's Mailman School of Public HealthCredit: CC0 Public DomainRacial inequities in maternal morbidity and mortality persist into the postpartum period, leading to a higher
OB & GYN January 16,2024
Predicting postpartum hospitalizations among high-risk populations

Predicting postpartum hospitalizations among high-risk populations

byColumbia University's Mailman School of Public HealthCredit: CC0 Public DomainRacial inequities in maternal morbidity and mortality persist into the postpartum period, leading to a higher
OB & GYN January 16,2024
First oral neurosteroid treatment for postpartum depression approved

First oral neurosteroid treatment for postpartum depression approved

by Sunitha Konatham,Texas A&M UniversityGraphical abstract. Credit:Psychopharmacology(2023). DOI: 10.1007/s00213-023-06427-2On Aug. 4, 2023, the United States Food and Drug Admin
OB & GYN January 16,2024
First oral neurosteroid treatment for postpartum depression approved

First oral neurosteroid treatment for postpartum depression approved

by Sunitha Konatham,Texas A&M UniversityGraphical abstract. Credit:Psychopharmacology(2023). DOI: 10.1007/s00213-023-06427-2On Aug. 4, 2023, the United States Food and Drug Admin
OB & GYN January 16,2024
Cannabis use during pregnancy associated with adverse birth outcomes

Cannabis use during pregnancy associated with adverse birth outcomes

by Society for the Study of AddictionCredit: Unsplash/CC0 Public DomainInfants prenatally exposed to cannabis are more likely to be born preterm, have a low birth weight, and require neonatal intensiv
OB & GYN January 16,2024
Cannabis use during pregnancy associated with adverse birth outcomes

Cannabis use during pregnancy associated with adverse birth outcomes

by Society for the Study of AddictionCredit: Unsplash/CC0 Public DomainInfants prenatally exposed to cannabis are more likely to be born preterm, have a low birth weight, and require neonatal intensiv
OB & GYN January 16,2024
Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva
Oncology January 16,2024
Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva
Oncology January 16,2024
Report: 2020 to 2021 saw rise in total number, rate, ratio of abortions

Report: 2020 to 2021 saw rise in total number, rate, ratio of abortions

by Elana GotkineFrom 2020 to 2021, there were increases in the total number, rate, and ratio of reported abortions, according to research published in the Nov. 24 issue of the U.S. Centers for Disease
OB & GYN January 16,2024
Report: 2020 to 2021 saw rise in total number, rate, ratio of abortions

Report: 2020 to 2021 saw rise in total number, rate, ratio of abortions

by Elana GotkineFrom 2020 to 2021, there were increases in the total number, rate, and ratio of reported abortions, according to research published in the Nov. 24 issue of the U.S. Centers for Disease
OB & GYN January 16,2024
Two easy fixes could reduce bleeding after cesarean delivery

Two easy fixes could reduce bleeding after cesarean delivery

by American Society of AnesthesiologistsCredit: Pixabay/CC0 Public DomainTwo simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research pres
OB & GYN January 16,2024
Two easy fixes could reduce bleeding after cesarean delivery

Two easy fixes could reduce bleeding after cesarean delivery

by American Society of AnesthesiologistsCredit: Pixabay/CC0 Public DomainTwo simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research pres
OB & GYN January 16,2024
Stress granules may drive obesity-associated pancreatic cancer

Stress granules may drive obesity-associated pancreatic cancer

byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For
Oncology January 16,2024
Stress granules may drive obesity-associated pancreatic cancer

Stress granules may drive obesity-associated pancreatic cancer

byThomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainObesity is a known risk factor for at least13 types of cancer, in part because it creates ever-present inflammatory state. For
Oncology January 16,2024
Antidepressants taken during pregnancy may affect children's digestive health

Antidepressants taken during pregnancy may affect children's digestive health

byAmerican Physiological SocietyNumber of EC cells is not significantly different between FLX-exposed and control colon. EC cells were identified by immunolabeling with antibodies to 5-HT and co
OB & GYN January 16,2024
Antidepressants taken during pregnancy may affect children's digestive health

Antidepressants taken during pregnancy may affect children's digestive health

byAmerican Physiological SocietyNumber of EC cells is not significantly different between FLX-exposed and control colon. EC cells were identified by immunolabeling with antibodies to 5-HT and co
OB & GYN January 16,2024
TV shows depicting inaccurate childbirths need safety warnings, say researchers

TV shows depicting inaccurate childbirths need safety warnings, say researchers

byKing's College LondonCredit: Pixabay/CC0 Public DomainU.K. television programs showing inaccurate birthing practices should require safety recommendations for viewers to avoid misinterpret
OB & GYN January 16,2024
TV shows depicting inaccurate childbirths need safety warnings, say researchers

TV shows depicting inaccurate childbirths need safety warnings, say researchers

byKing's College LondonCredit: Pixabay/CC0 Public DomainU.K. television programs showing inaccurate birthing practices should require safety recommendations for viewers to avoid misinterpret
OB & GYN January 16,2024
Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge
Oncology January 16,2024
Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge
Oncology January 16,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com